Sutro Biopharma (STRO) stock news · rev $102.5M
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
This STRO news page leads with what Sutro Biopharma filed — not a scraped headline mill.
No cached 8-K sentence for STRO yet. We will not pad this page with generic market recap.
Latest reported STRO revenue for 2025-12-31 was $102.5M. Net income was -$191.1M. Revenue was up 65.2% from 2024-12-31 to 2025-12-31. STRO currently screens at market cap $470.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the STRO stock page; for the tape open the quote page.
STRO stock news FAQ
What are STRO's latest revenue and net income?
Latest cached Sutro Biopharma (STRO) revenue for Dec 31, 2025 was $102.5M. Net income was -$191.1M. Statements: https://lician.com/financials/stro
How did STRO revenue change from the prior cached period?
Cached Sutro Biopharma (STRO) revenue was up 65.2% from $62.0M (Dec 31, 2024) to $102.5M (Dec 31, 2025). Statements: https://lician.com/financials/stro
What is STRO's market cap?
Sutro Biopharma (STRO) market cap is $470.8M on the latest cached fundamentals snapshot.
What kind of company is STRO?
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Where is STRO stock news listed?
Cached stock news for Sutro Biopharma (STRO) is listed at https://lician.com/news/stro. Filings: https://lician.com/sec/stro
Not investment advice.